 |
Ikano Therapeutics Inc. (ITI) is a private company founded in 2009 building upon the foundation work by Intranasal Therapeutics Inc. |
Welcome to ITI
As of November 22nd, 2010, Ikano Therapeutics Inc. is closing its business and dissolving, following the completion of our previously announced agreement with Upsher-Smith Laboratories, Inc. transferring the ownership of our ITI-111 nasal midazolam program for the treatment of acute epileptic seizure.
If you have business pertaining to Ikano Therapeutics Inc. after this date, please contact:
Ikano Therapeutics Liquidating Trust
c/o Shareholder Representative Services LLC
601 Montgomery Street, Suite 2020
San Francisco, CA 94111
Attention: Managing Director
Email: ikano@shareholderrep.com
Facsimile No.: (415) 962-4147
Telephone No.: (415) 367-9400
Comfort.
Convenience.
Control.
Our lead products are nasally delivered which have many benefits over alternative therapies, with the potential to enhance the health and well-being of those who use them. MORE
Contact Us
For more information about our current products or the drug delivery potential of others, please contact us: info@ikanotherapeutics.com
